BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2011
View Archived Issues
Japanese scientists describe miRNAs in plasma and synovial fluid as biomarkers for RA and OA
Read More
AM-432 is active in models of inflammatory respiratory conditions
Read More
New prostanoid EP4 receptor antagonist MF-592 has promising preclinical profile
Read More
Activators of ERK signaling may provide new therapeutic approach for HD
Read More
Lapatinib plus capecitabine does not improve survival of patients with metastatic pancreatic cancer
Read More
Phase Ib trials assess drozitumab-based combination regimens in advanced mCRC
Read More
Gilead Sciences presents new antiviral compounds
Read More
Soligenix and University of Colorado enter agreement for thermostable vaccines
Read More
Eisai establishes subsidiary to develop next-generation cancer drugs
Read More
Novel agonists of cannabinoid CB1 and CB2 receptors disclosed
Read More
New adenosine A2B receptor antagonists claimed by PGxHealth
Read More
Bayer and Zydus Cadila form joint company in India to optimize product portfolios
Read More
Arena Pharma provides update on lorcaserin and its pipeline
Read More
Pathway Therapeutics divulges novel PI3K inhibitors
Read More
MorphoSys receives milestone payment from OncoMed Pharma for phase I OMP-59R5 trial
Read More
CSL Behring's Berinert approved in Israel for acute HAE
Read More
Pfizer issues milestone payment to MorphoSys regarding phase I testing of HuCAL-derived antibody
Read More
Antisoma discontinues development of AS-1413 in secondary AML
Read More
FDA approves Menveo vaccine for children but refuses sBLA for use in infants
Read More
Collaboration launched to develop biomarker predicting response to PF-01367338
Read More
Rituxan approved in U.S. for first-line maintenance use in follicular lymphoma
Read More
AMT receives grant to develop AMT-021 for acute intermittent porphyria
Read More
Verona Pharma seeks U.K. clearance for clinical trials of RPL-554
Read More
European Commission approves Johnson & Johnson's acquisition of Crucell
Read More
FDA approves Gralise for once-daily treatment of postherpetic neuralgia
Read More